Can chemical additives in breakfast cereals and other everyday products help make you obese? Growing evidence from animal experiments suggests the answer may be “yes,” but confirming these findings in humans has been daunting.
News & Notes
To help address the nation’s opioid crisis, Cedars-Sinai is investigating the best way to discuss these highly addictive drugs with chronic pain patients.
The infant brain is famously pliable, an organ of explosive growth and unparalleled adaptability. But this period of rapid development comes with a large dose of vulnerability.
What if you could coax broken bones to regrow their own tissue? A pioneering method combining stem cells and gene therapy may do just that.
Depression can lead to poor outcomes for a slew of medical conditions, as patients who suffer from depression are less likely to take their medications and return for follow-up appointments. This, in turn, can delay recovery, lengthen hospital stays, and increase risk of readmission.
It’s well-known that the number of kidney donors falls far short of the number of people in need of a kidney transplant. What’s less known is an extraordinary pay-it-forward solution to the shortage that involves a chain of Good Samaritans and makes it possible for more men and women on the waitlist to receive a new organ.
Bruce Ettinger is CEO of Frame Health, a graduate of the Cedars-Sinai Accelerator Powered by Techstars — an incubator for healthcare start-ups.
Physicians don’t need new machines to predict congenital heart defects in newborns — they just need to better use existing resources.